DRB (HIV Transcription Inhibitor): Innovating RNA Polymer...

2025-10-21

DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole) stands out as a versatile transcriptional elongation and CDK inhibitor, enabling precise dissection of HIV transcription, cell cycle regulation, and antiviral mechanisms. Its unique solubility and mechanistic specificity make it indispensable for advanced workflows in HIV, cancer, and stem cell research.